1Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa, Italy; 2Institute of Clinical Physiology, National Research Council, Pisa, Italy; 3Division of Surgical Oncology, National Cancer Institute, Genoa, Italy; 4Division of Surgical Oncology, Department of Oncology, Biology and Genetics, University of Genoa and National Cancer Institute, Genoa, Italy; 5Nuclear Medicine Se...

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up M. Sørensen, M. Pijls-Johannesma & E. Felip On behalf of the ESMO Guidelines Working Group* Department of Oncology, The Finsen Centre, Copenhagen, Denmark; Department of Radiation Oncology, MAASTRO Clinic, GROW Research Institute, Maastricht University Medical Center, Maastricht, The Netherlands; Me...

1Pediatric Hematology and Oncology, University of Frankfurt, Germany; 2Department of Pediatric Hematology and Oncology, Hannover Medical School, Germany; 3Children’s Cancer Research Institute, St Anna Kinderspital and Children’s Cancer Research Institute (CCRI), Vienna, Austria; 42nd Medical School, Charles University, Prague, Czech Republic; 5Department of Pediatric Hematology and Oncology, Un...

Department of Pediatric Hemato-Oncology, Edmond and Lily Safra Children’s Hospital, Sheba Medical Centre, Tel-Hashomer, Ramat Gan, and Tel Aviv University Medical School, Tel Aviv, Israel; Department of Haematology, Sheffield Children’s Hospital, Sheffield, United Kingdom; Pediatric Oncology/ Hematology, Erasmus MC–Sophia Children’s Hospital, Rotterdam, The Netherlands; and Division of Haematol...

1Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany; 2Department of Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany; 3Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany; 4Department of Internal Medicine III, University of Frankfurt, Frankfurt, Germany; and 5Depa...

From the Divisions of Hematology-Oncology and Medical Oncology, Department of Medicine, the Division of Epidemiology and Biostatistics, and the Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, I-20141, Italy; The Sunnybrook and Women’s College Health Sciences Centre, Molecular and Cellular Biology, Department of Medical Biophysics, University of Toronto, Tor...

Invasive bladder cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up J. Bellmunt, S. Albiol & V. Kataja On behalf of the ESMO Guidelines Working Group* Department of Medical Oncology, University Hospital del Mar; Department of Medical Oncology, Instituto Oncológico Teknon, Barcelona, Spain; Department of Oncology, Vaasa Central Hospital, Vaasa and Kuopio University Hosp...

Department of Gynecology and Obstetrics, Innsbruck Medical University, Innsbruck, Austria; Laboratory of Molecular Oncology, Department of Molecular Medicine, Rudjer Boskovic Institute, Zagreb, Croatia; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria; Department of Obstetrics and Gynecology, Staedtische Kliniken, Frankfurt, German...

Harvard Medical School, Boston, Massachusetts Department of Neurosurgery, Dana-Farber/Brigham & Women’s Cancer Center, Boston, Massachusetts Department of Pathology, Dana-Farber/Brigham & Women’s Cancer Center, Boston, Massachusetts York Hospital Oncology, York, Maine Department of Medical Oncology, Dana-Farber/Brigham & Women’s Cancer Center, Boston, Massachusetts Department of Radiation Oncol...